Israel has had a robust and solid medical cannabis program for more than 30 years, a strong R&D and innovation center and a large percentage of adult usage, yet recreational…
COVID-19 Impact In the first half of 2020, CBD companies are experiencing a loss in revenue due to store closures and consumer concerns about Coronavirus and their finances. Shelter-at-home policies…
When Rylie Maedler addresses an audience there's rarely a dry eye left in the room. By the end of her story, Rylie has gotten under your skin, into your heart…
When I was at Pharmacy School at Sydney University, more than 20 years ago, we learned the pharmaceutical and clinical sciences ranging from the design, synthesis, formulation, dispensing and testing…
What a stressful time this is for all of us. People across the globe have been affected by a new, severe, physical illness making the headlines. Perhaps the constant daily…
Cannabis Investing in a Coronavirus World 60 days ago, cannabis investors were excited about 2020. More states and countries legalized, supply chains were ready, and customer demand was growing…
In 2020, we are celebrating five years of CannaTech global cannabis conferences. Each of these has taken us to different continents and contributed to our growing ecosystem. CannaTech is an…
Last week, my team and I were in Davos for the annual meeting of the World Economic Forum. We were not participating in the official WEF events and did not…
Why do we care so much about European Cannabis Market Growth? By Isracann Biosciences Today, Europe makes up 9.78% of the world’s population, roughly 740 million people spread across 28 countries. That’s over…
Cam Battley is stepping down as Chief Corporate Officer of Aurora Cannabis to pursue a role as director of Aurora partner company MedReleaf Australia. A passionate spokesperson for the medical…
